Clinical Trials · NCT00002651

SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
SWOG Cancer Research Network
Enrollment
3,040
Start date
May 1995
Locations
14 sites, Canada
Primary endpoint
Overall Survival
View Gonadorelin compound reference